Skip to main content
Premium Trial:

Request an Annual Quote

LJL Biosystems Ships Its Analyst HTS Product To Millennium Pharma


SUNNYVALE, Calif.--LJL Biosystems here announced last week that it has released its new high-throughput screening product, the Analyst, for commercial shipments. The product is expected to enable drug discovery labs to perform multiple assays with increased throughput sensitivity and reduced costs per assay, and is designed to perform 5-10 million assays per year, the company said. The first commercial shipment of the Analyst was to Millennium Pharmaceuticals. LJL CEO Lev Leytes said he believes the new technology will fundamentally change the drug discovery process by providing scientists with a more efficient, less costly assay detection process.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.